Status:
RECRUITING
CT-based Myocardial Characterization (CTMyoC)
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
18-100 years
Brief Summary
The identification of myocardial fibrosis in term of myocardial scar and extracellular matrix remodelling assessed respectively with the technique of Late Gadolinium Enhancement (LGE) and with the qua...
Eligibility Criteria
Inclusion
- age ≥ 18 years;
- no contraindication to cCT
- signed informed consent
- clinical indication to cCT for the following reason: stable angina, heart failure, atrial/ ventricular arrhythmias, acute chest pain with need of "triple-rule-out" scan, planning of valvular repair/substitution, structural and infiltrative cardiomyopathy, new onset ECG alteration, troponin increase.
Exclusion
- age \< 18 years
- pregnancy and/or breastfeeding
- contraindications to iodinated contrast agent administration or impaired renal function (eGFR ≤ 30 mL/min);
- inability to sustain a brief breath hold (5 seconds)
Key Trial Info
Start Date :
October 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 12 2032
Estimated Enrollment :
2200 Patients enrolled
Trial Details
Trial ID
NCT06029400
Start Date
October 12 2020
End Date
October 12 2032
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele
Milan, Italy